Streetbeat News

Stock Prices

SPCB

SuperCom shares are experiencing an increase in trading value following the announcement of a new contract in New York State.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 1:09 pm

XTNT

Xtant Medical shares rose following the launch of OsteoVive Plus, a new moldable viable bone matrix for grafting procedures.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 1:08 pm

VVOS

Vivos Therapeutics shares rose following the announcement of FDA 510(k) clearance for a device to treat moderate to severe pediatric sleep apnea and snoring.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 1:05 pm

BA

Boeing and its largest union have resumed talks with federal mediators after 30,000 workers went on strike over wages and pensions. This development is crucial for Boeing as it seeks to resolve labor disputes that could impact its operations.

Portfolio Pulse from Akanksha Bakshi

September 18, 2024 | 1:03 pm

AZTR

Azitr Shares are rising following the FDA's Fast Track Designation for ATR-04, a topical treatment for dermal toxicity associated with Epidermal Growth Factor Receptor inhibitors.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 1:02 pm

APDN

Applied DNA Sciences has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the exchange. This development is crucial for maintaining investor confidence and market presence.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 1:02 pm

FIGS

FIGS is expanding its retail presence by opening a second community hub in Philadelphia's Rittenhouse neighborhood, following the success of its first hub in Los Angeles. This move marks FIGS' growth strategy to increase its physical retail footprint.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 1:01 pm

ZTS

Zoetis (NYSE:ZTS) has received varied analyst ratings over the last quarter, with most being bullish. Analysts have raised their 12-month price targets, reflecting a positive outlook. Zoetis's financial metrics, such as revenue growth and net margin, are strong, though its market capitalization is below industry benchmarks.

Portfolio Pulse from Benzinga Insights

September 18, 2024 | 1:01 pm

RELY

In the past three months, six analysts have provided ratings for Remitly Global (NASDAQ:RELY), ranging from bullish to bearish. The average 12-month price target is $21.67, with a high of $30.00 and a low of $13.00. Recent analyst actions include both upgrades and downgrades, reflecting varied perceptions of the company's market standing. Remitly Global has shown strong revenue growth but faces challenges in profitability and financial returns.

Portfolio Pulse from Benzinga Insights

September 18, 2024 | 1:00 pm

SAFE

Safehold (NYSE:SAFE) has received mixed analyst ratings over the past three months, with a recent trend towards more bullish outlooks. Analysts have raised their price targets, with the average target now at $28.5, reflecting a 25.27% increase from previous estimates. Safehold's financial performance shows strong profitability and effective asset utilization, though its revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

September 18, 2024 | 1:00 pm